Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

The antibody–drug conjugate SHR-A1904 for targeting CLDN18.2 in advanced gastric or gastroesophageal junction cancer: a phase 1 trial

Title:	The antibody–drug conjugate SHR-A1904 for targeting CLDN18.2 in advanced gastric or gastroesophageal junction cancer: a phase 1 trial
Authors:	Ruan, Dan-Yun^{Aff1, Aff2}; Wu, Hao-Xiang^{Aff1, Aff2}; Luo, Su-Xia^Aff3; Huang, Wen-Wen^{Aff1, Aff2}; Liang, Xin-Jun^Aff4; Niu, Zuo-Xing^Aff5; Dang, Qi^Aff6; Li, Hong-Li^Aff7; Pan, Zhan-Yu^Aff8; Lu, Hong-Xia^Aff9; Zhang, Yan-Qiao^Aff10; Li, Xing-Ya^Aff11; Xiao, Xiu-Ying^Aff12; Cai, Shi-Rong^Aff13; Dong, Yu-Gang^Aff14; Zhang, Jian^Aff15; Li, Zhou^Aff16; Lan, Hai-Tao^Aff17; Wang, Xin^Aff18; Zhou, Ying^Aff19; Liu, Lian^Aff20; Liu, He-Li^Aff21; Xu, Ping-Sheng^Aff22; Suo, Ai-Li^Aff23; Jia, Rui-Nuo^Aff24; Li, Yong-Qiang^Aff25; Peng, Xiao-Dong^Aff26; Wang, Si-Chen^Aff27; Yu, Ai-Ai^Aff28; Xie, Jie^Aff29; Qiu, Miao-Zhen^{Aff2, Aff30, IDs4159102503781w_cor1}; Xu, Rui-Hua^{Aff2, Aff30, IDs4159102503781w_cor2}
Source:	Nature Medicine. 31(9):3037-3046
Database:	Springer Nature Journals